Quantcast
Published On: Mon, Nov 18th, 2013

Princeton hopes to make Bexsero available for students in December

In a follow-up to an earlier story, Princeton University announced today via email that they will be receiving the EU/Australia approved meningococcal meningitis vaccine, Bexsero, to offer to immunize students against Neisseria meningitidis serogroup B, according to an email sent out Nov.18.

meningococcus

Neisseria meningitidis
Image/CDC

According to the email:

The CDC is preparing to recommend that all Princeton University undergraduate students (those who live in dormitories or off campus) and graduate students who live in dormitories receive a vaccine that helps protect against meningococcal disease caused by serogroup B. The CDC would recommend that other members of the University community with functional and anatomic asplenia (including sickle cell disease) and late complement component deficiencies also should receive the vaccine. Based on the CDC’s assessment of the cases at Princeton, only these groups would be recommended to receive the vaccine.

Pending final CDC approval, the University is prepared to accept these recommendations and make arrangements to provide access to this vaccine as soon as possible.

The University says they hope to have the first of the two-part series available for those groups listed above in early December.

The second dose of the series would be administered in February. They clearly state that the vaccine  would be made available to these groups only.

The two doses of the vaccine, Bexsero, are required for maximum protection. Princeton says they will cover the cost of the vaccine for the student population that requests it.

This follows the university reporting seven confirmed cases of meningococcal meningitis B since March 2013.

For more infectious disease news and information, visit and “like” the Infectious Disease News Facebook page

Looking for a job in health care? Check here to see what’s available

On the DISPATCH: Headlines  Local  Opinion

Subscribe to Weekly Newsletter

* indicates required
/ ( mm / dd ) [ALL INFO CONFIDENTIAL]

About the Author

- Writer, Co-Founder and Executive Editor of The Global Dispatch. Robert has been covering news in the areas of health, world news and politics for a variety of online news sources. He is also the Editor-in-Chief of the website, Outbreak News Today and hosts the podcast, Outbreak News Interviews on iTunes, Stitcher and Spotify Robert is politically Independent and a born again Christian Follow @bactiman63

Tags
Displaying 1 Comments
Have Your Say
  1. Princeton University reports 8th meningitis case - The Global Dispatch says:

    […] University reported last week they plan on offering a vaccine that can protect against meningitis serotype B, Novartis’ […]

Leave a comment

XHTML: You can use these html tags: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <s> <strike> <strong>

Sign up for our Weekly Newsletter



Categories

Archives

At the Movies

Pin It